Adis Journals
Summary Slide.png (109.08 kB)

Cost-Effectiveness of Vedolizumab in the Treatment of Moderate-to-Severe Crohn’s Disease in China

Download (109.08 kB)
posted on 2021-06-03, 13:43 authored by Adis Journals on behalf of, Ting Zhou, Yanan Sheng, Haijing Guan

Article full text

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2021.